A crucial deadline for shareholders of German private equity firm Mutares SE & Co. KGaA passed today, April 21, 2026. The subscription period for the company’s ongoing capital increase has now closed, with any unexercised rights expiring without compensation. The move comes as the company’s stock trades perilously close to the subscription price, having recently touched a 12-month low.
The offering, priced at €24.50 per share, saw the stock trading at just €25.05 in recent sessions. This narrow premium underscores recent pressure, with the share having shed roughly 17% over the past 30 days and sitting nearly 15% below its 200-day moving average. The equity recently hit a 52-week low of €24.90, contributing to a year-to-date decline exceeding 16%.
Proceeds from the capital raise, which could bring in up to €105 million gross from the issuance of up to 4.27 million new shares, are earmarked for a dual purpose. Approximately 80% is allocated for international expansion, specifically targeting growth in the United States and new opportunities in Europe. The company, which already has an office in Chicago, plans to open a second US location. A robust transaction pipeline in the region, with a potential deal volume of nearly €5 billion, awaits deployment.
The remaining 20% of the fresh capital is destined to fortify the balance sheet, addressing an immediate concern. Based on preliminary 2025 figures, management expects to breach a financial covenant tied to its bond terms, specifically the net debt to equity ratio. This was attributed to valuation effects, fewer equity-positive transactions in Q4 2025, and significantly increased leasing liabilities. In response, Mutares has requested a waiver from bondholders, suspending the covenant until June 29, 2026, and has outlined a repayment plan to buy back at least €25 million of its 2023/2027 bond per quarter starting in Q2 2026.
Should investors sell immediately? Or is it worth buying Mutares?
The institutional placement preceding the retail offering was heavily oversubscribed, with the book covered nearly three times. Professional investors snapped up roughly 1.08 million shares, with over 60% of demand originating from abroad, primarily the United States and Great Britain.
Operationally, the company’s performance provides a counterpoint to its balance sheet challenges. Consolidated revenue for 2025 climbed to €6.5 billion. The holding company’s annual net profit rose to €130.4 million, up from €108.3 million a year earlier. For the current year, management is targeting revenue between €7.9 billion and €9.1 billion, with net profit forecast to reach €165 to €200 million.
Concurrently, Mutares is actively reshaping its portfolio. Its logistics subsidiary, inTime Group, is being sold to Tawin Holdings Group. Mutares had only acquired the company in August 2025 and subsequently executed an operational restructuring.
Investors now look ahead to several key dates. The new shares from the subscription offering will be delivered and admitted to trading on April 28. That same day, the company will publish its complete, audited annual report for 2025. The first-quarter report for 2026 is scheduled for May 12, with the annual general meeting set for July 3.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from April 21 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 21.
Mutares: Buy or sell? Read more here...
